iShares Genomics Immunology and Healthcare ETF
IDNA
51 hedge funds and large institutions have $49.1M invested in iShares Genomics Immunology and Healthcare ETF in 2025 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 17 increasing their positions, 12 reducing their positions, and 5 closing their positions.
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
42% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 12
11% more capital invested
Capital invested by funds: $44.1M → $49.1M (+$4.99M)
9% more funds holding
Funds holding: 47 → 51 (+4)
0.37% less ownership
Funds ownership: 41.73% → 41.36% (-0.37%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$536K |
| 2 |
PP
Prudential plc
London, England,
United Kingdom
|
+$442K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$399K |
| 4 |
Raymond James Financial
St Petersburg,
Florida
|
+$278K |
| 5 |
AIA
Ally Invest Advisors
Charlotte,
North Carolina
|
+$211K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.69M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$851K |
| 3 |
CCA
Cora Capital Advisors
Marlton,
New Jersey
|
-$799K |
| 4 |
CCA
Clearwater Capital Advisors
Hoffman Estates,
Illinois
|
-$507K |
| 5 |
FTUS
Flow Traders U.S.
New York
|
-$391K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
WANY
51
Wealthspire Advisors (New York)
New York
| $534 | +$509 | +23 | New |
|
|
52
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$851K | -41,505 | Closed |
|
|
CCA
53
Cora Capital Advisors
Marlton,
New Jersey
| – | -$799K | -38,960 | Closed |
|
54
Simplex Trading
Chicago,
Illinois
| – | -$4K | -241 | Closed |
|
|
AAS
55
Ameritas Advisory Services
Lincoln,
Nebraska
| – | -$410 | -20 | Closed |
|
|
EWM
56
Evolution Wealth Management
Fort Myers,
Florida
| – | -$205 | -10 | Closed |
|
IDNA Hedge Fund Activity: Q3 2025 in Review
51 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in iShares Genomics Immunology and Healthcare ETF (IDNA) for Q3 2025, worth a combined $49.1M — up 11% from $44.1M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new IDNA positions and 5 closed out — a net gain of 4 holders — while 17 added to existing stakes and 12 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $536K. The largest seller was Morgan Stanley, cutting an estimated $1.69M.
- 51 institutional investors held iShares Genomics Immunology and Healthcare ETF (IDNA) as of Q3 2025, up from 47 in Q2 2025.
- Funds reported $49.1M of iShares Genomics Immunology and Healthcare ETF stock for Q3 2025, up 11% quarter-over-quarter.
- 9 funds opened new iShares Genomics Immunology and Healthcare ETF positions in Q3 2025 and 5 closed out, a net change of +4 holders.
- The largest iShares Genomics Immunology and Healthcare ETF buyer in Q3 2025 was Citadel Advisors, an estimated $536K added.
- The largest iShares Genomics Immunology and Healthcare ETF seller in Q3 2025 was Morgan Stanley, an estimated $1.69M sold.
Based on aggregated 13F filings for Q3 2025.